Standout Papers

Second consensus statement on the diagnosis of multi... 1994 2026 2004 2015 2.2k
  1. Second consensus statement on the diagnosis of multiple system atrophy (2008)
    S. Gilman, Gregor K. Wenning et al. Neurology
  2. A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa (2000)
    Olivier Rascol, David J. Brooks et al. New England Journal of Medicine
  3. Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease (2003)
    Steven S. Gill, Nikunj K. Patel et al. Nature Medicine
  4. Motor sequence learning: a study with positron emission tomography (1994)
    David J. Brooks, R. S. J. Frackowiak et al. Journal of Neuroscience
  5. Three‐dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe (2003)
    Alexander Hammers, R. Allom et al. Human Brain Mapping
  6. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease (2005)
    Alexander Gerhard, Nicola Pavese et al. Neurobiology of Disease
  7. The functional anatomy of motor recovery after stroke in humans: A study with positron emission tomography (1991)
    François Chollet, Vittorio Di Piero et al. Annals of Neurology
  8. Core assessment program for intracerebral transplantations (CAPIT) (1992)
    J. William Langston, Håkan Widner et al. Movement Disorders
  9. Evidence for striatal dopamine release during a video game (1998)
    Matthias J. Koepp, Roger N. Gunn et al. Nature
  10. In-vivo measurement of activated microglia in dementia (2001)
    Annachiara Cagnin, David J. Brooks et al. The Lancet
  11. Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system (2005)
    Philippe Rémy, M Doder et al. Brain
  12. Inflammation after trauma: Microglial activation and traumatic brain injury (2011)
    Anil Ramlackhansingh, David J. Brooks et al. Annals of Neurology
  13. Self-initiated versus externally triggered movements (2000)
    I. H. Jenkins, Marjan Jahanshahi et al. Brain
  14. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study (2003)
    Alan Whone, Ray L. Watts et al. Annals of Neurology
  15. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study (2004)
    Martin R. Turner, Annachiara Cagnin et al. Neurobiology of Disease
  16. Survival of Implanted Fetal Dopamine Cells and Neurologic Improvement 12 to 46 Months after Transplantation for Parkinson's Disease (1992)
    Curt R. Freed, Robert E. Breeze et al. New England Journal of Medicine
  17. 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study (2010)
    Juha O. Rinne, David J. Brooks et al. The Lancet Neurology
  18. Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study (1992)
    E. Diane Playford, I. H. Jenkins et al. Annals of Neurology
  19. Anatomy of Motor Learning. I. Frontal Cortex and Attention to Action (1997)
    M. Jueptner, K.M. Stephan et al. Journal of Neurophysiology
  20. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient (1999)
    Paola Piccini, David J. Brooks et al. Nature Neuroscience
  21. 18F‐flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial (2010)
    Rik Vandenberghe, Koen Van Laere et al. Annals of Neurology

Immediate Impact

5 by Nobel laureates 28 from Science/Nature 131 standout
Sub-graph 1 of 16

Citing Papers

Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease
2025 StandoutNature
Alzheimer's disease: From immunotherapy to immunoprevention
2023 Standout
102 intermediate papers

Works of David J. Brooks being referenced

Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
2012
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
2010 Standout
and 55 more

Author Peers

Author Last Decade Papers Cites
David J. Brooks 30960 19605 6822 12175 716 59.9k
Andrew J. Lees 55031 20679 3116 8690 728 72.6k
Glenda M. Halliday 29271 13334 2469 6596 645 49.5k
Anthony E. Lang 56088 24236 2488 10230 889 74.7k
C. D. Marsden 33459 21920 2160 14828 717 65.7k
Werner Poewe 42303 13727 2538 8946 679 56.2k
Yves Agid 31073 25204 1776 8406 603 54.2k
K. A. Jellinger 21187 11000 2045 5259 1.0k 47.3k
Heiko Braak 25978 16106 4893 11341 358 66.6k
Joseph Jankovic 43664 18831 1470 5317 804 57.9k
Mark Hallett 27340 13645 4316 26062 836 64.6k

All Works

Loading papers...

Rankless by CCL
2026